Insights

Global expansion Intas operates in 85+ countries with a global sales orientation and a large private Indian generic footprint, presenting cross-border partnering and distribution opportunities across EU, US, UK, and emerging markets.

Biosimilar momentum With a dedicated EU-GMP certified Biopharma division and recent launches of monoclonal antibody biosimilars, there are clear opportunities to license, co-market, or supply biosimilar products in regulated markets.

R&D pipeline A robust R&D investment of 6-7% of revenue and a pipeline of 300+ high-value products including FTF/FTM and NDDS suggest multiple near-to-midterm products suitable for strategic alliances, tech transfers, or joint development.

Regulatory footprint Global regulatory accreditations (USFDA, EMA, MHRA, TGA) across facilities enable faster onboarding for high-compliance partnerships, contract manufacturing, and supply agreements with risk mitigations.

Recent partnerships Active collaboration activity with Kashiv BioSciences and IntegriMedical indicates openness to licensing, supply agreements, and strategic alliances that can be expanded to new regions and product classes, including complex biologics.

Intas Pharmaceuticals Tech Stack

Intas Pharmaceuticals uses 8 technology products and services including Azure Kubernetes Service, Azure DevOps, Google Workspace, and more. Explore Intas Pharmaceuticals's tech stack below.

  • Azure Kubernetes Service
    Containerization
  • Azure DevOps
    Devops
  • Google Workspace
    Email
  • Twemoji
    Font Scripts
  • jQuery Migrate
    Javascript Libraries
  • Visual Basic .NET
    Programming
  • Smartsheet
    Project Management
  • Google Search Console
    Web Analytics

Media & News

Intas Pharmaceuticals's Email Address Formats

Intas Pharmaceuticals uses at least 1 format(s):
Intas Pharmaceuticals Email FormatsExamplePercentage
First_Last@intaspharma.comJohn_Doe@intaspharma.com
94%
FirstLast@intaspharma.comJohnDoe@intaspharma.com
3%
FLast@intaspharma.comJDoe@intaspharma.com
2%
F_Last@intaspharma.comJ_Doe@intaspharma.com
1%

Frequently Asked Questions

What is Intas Pharmaceuticals's phone number?

Minus sign iconPlus sign icon
You can contact Intas Pharmaceuticals's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Intas Pharmaceuticals's official website and social media links?

Minus sign iconPlus sign icon
Intas Pharmaceuticals's official website is intaspharma.com and has social profiles on LinkedInCrunchbase.

What is Intas Pharmaceuticals's SIC code NAICS code?

Minus sign iconPlus sign icon
Intas Pharmaceuticals's SIC code is 2834 - Pharmaceutical Preparations NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Intas Pharmaceuticals have currently?

Minus sign iconPlus sign icon
As of July 2026, Intas Pharmaceuticals has approximately 20K employees across 6 continents, including AsiaSouth AmericaNorth America. Key team members include Chief Executive Officer: R. J. M.Chief Executive Officer: V. B.Cfo: J. S.. Explore Intas Pharmaceuticals's employee directory with LeadIQ.

What industry does Intas Pharmaceuticals belong to?

Minus sign iconPlus sign icon
Intas Pharmaceuticals operates in the Pharmaceutical Manufacturing industry.

What technology does Intas Pharmaceuticals use?

Minus sign iconPlus sign icon
Intas Pharmaceuticals's tech stack includes Azure Kubernetes ServiceAzure DevOpsGoogle WorkspaceTwemojijQuery MigrateVisual Basic .NETSmartsheetGoogle Search Console.

What is Intas Pharmaceuticals's email format?

Minus sign iconPlus sign icon
Intas Pharmaceuticals's email format typically follows the pattern of First_Last@intaspharma.com. Find more Intas Pharmaceuticals email formats with LeadIQ.

How much funding has Intas Pharmaceuticals raised to date?

Minus sign iconPlus sign icon
As of July 2026, Intas Pharmaceuticals has raised $306M in funding. The last funding round occurred on Oct 10, 2022.

When was Intas Pharmaceuticals founded?

Minus sign iconPlus sign icon
Intas Pharmaceuticals was founded in 1976.
Intas Pharmaceuticals logo

Intas Pharmaceuticals

Pharmaceutical ManufacturingGujarat, India10001+ Employees

Intas Pharmaceuticals, headquartered in Ahmedabad, Gujarat, India, operates as a multinational organization involved in formulation development, manufacturing, and marketing. It maintains a broad global footprint through Accord Healthcare subsidiaries spanning the EU, US, Canada, South Africa, Australia, APAC, and the CIS and MENA regions, with a presence in more than 85 countries. The company has established leadership in several therapeutic areas in India and is among the top generic players in regulated markets such as the EU, US, and UK, while remaining privately owned.

Intas runs 17 facilities worldwide, including locations in India, the UK, Mexico, and Greece, supported by a large workforce and regulatory accreditations from agencies such as USFDA, EMA, MHRA, and TGA. It allocates a portion of its revenue to research and development and maintains a pipeline of more than 300 high-value products, including biosimilars and NDDS, alongside a EU-GMP certified biopharma division focused on biosimilars for oncology, auto-immune, ophthalmology, nephrology, rheumatology, and hormone therapies, as well as a plasma fractionation unit with an R&D laboratory.

Section iconCompany Overview

Phone number
SIC Code
2834 - Pharmaceutical Preparations
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1976
Employees
10001+

Section iconFunding & Financials

  • $306M

    Intas Pharmaceuticals has raised a total of $306M of funding over 6 rounds. Their latest funding round was raised on Oct 10, 2022as a secondary_market.

  • $1B$10B

    Intas Pharmaceuticals's revenue is estimated to be in the range of $1B$10B

Section iconFunding & Financials

  • $306M

    Intas Pharmaceuticals has raised a total of $306M of funding over 6 rounds. Their latest funding round was raised on Oct 10, 2022as a secondary_market.

  • $1B$10B

    Intas Pharmaceuticals's revenue is estimated to be in the range of $1B$10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.